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Volume 61, Number 2 Abstracts 585requiring dialysis, colonic ischemia requiring resection, limb ischemia
requiring amputation, multisystem organ failure, or death. Endoleaks
were classiﬁed in accordance with the standardized reporting practices of
the Society for Vascular Surgery.
Results: A total of 391 patients with complete family history and clin-
ical data underwent elective AAA repair from 2004 to 2014. Demographics
were consistent with a standard AAA population and did not differ between
fAAA and spAAA patients. Sixty-two percent (n ¼ 56) of fAAA patients and
68% (n ¼ 203) of spAAA patients underwent EVAR (P ¼ .31). The fAAA
patients did not incur any greater risk of major adverse events after EVAR
(fAAA: 11% vs spAAA: 9%; P ¼ .8) or open AAA repair (fAAA: 11% vs
spAAA: 15%; P ¼ .78). Despite no difference in major morbidity, the
fAAA patients did have an increased rate of all types of endoleak (fAAA:
23% vs spAAA: 12%; P ¼ .05). Furthermore, the rate of type I endoleak
and subsequent reintervention for type I endoleak did differ between the
groups (fAAA: 7% vs spAAA: 1%; P ¼ .02). In contrast, reintervention for
all types of endoleak after EVAR (fAAA: 13% vs spAAA: 8%; P ¼ .16) did
not differ between fAAA and spAAA patients.
Conclusions: The current study demonstrates that patients with fAAA
do not have increased morbidity after AAA repair but are more prone to
endoleak after EVAR. We believe our results, combined with those of others,
suggest EVAR for fAAA is safe and effective but fAAA patients represent a
subpopulation that would beneﬁt from close postprocedural surveillance.
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Objectives: We previously developed a Vascular Group of New En-
gland (VSGNE) risk-predictive model (RPM) to predict in-hospital mortality
(IHM) after elective abdominal aorta aneurysm repair (EAR). The purpose of
this study was to externally validate this model using American College of Sur-
geons’ National Surgical Quality Improvement Program (NSQIP) database
and evaluates its ability to predict mortality compared with established RPMs.
Methods: The VSGNE AAA database was queried for patients who
underwent EAR. Only preoperative variables, Anesthesia Society Associa-
tion (ASA) Physical Status Classiﬁcation, and type of procedure were
entered into a logistic regression model as predictors of IHM. Backward
elimination procedure with a level of 0.2 was used to select a more parsimo-
nious model. Calibration was performed to measure how closely predicted
outcomes agreed with observed outcomes. The predictive value of the
model was assessed via C statistic. The Hosmer-Lemeshow (HL) method
was used to assess calibration. The external validation of this model was per-
formed using the NSQIP EAR sample. This model was then compared with
Medicare and the Glasgow Aneurysm Score for predicting IHM in the
NSQIP sample. Vuong test was performed to compare model ﬁt. Model
discrimination was assessed in equally sized risk-group NSQIP terciles.
Results: Data from 2,681 patients from the VSGNE sample with
overall 1.3% IHM rate were used to develop a parsimonious AAA mortality
model (Table). The internally validated model showed a very high discrim-
inating ability (corrected C ¼ 0.805) and good model ﬁt (P ¼ .699 by HL).
External validation on 18,766 NSQIP patients with an overall 1.9% IHMTable. Abdominal aortic aneurysm (AAA) ﬁnal risk-predictive model
(RPM) of mortality
Variable B SE P value
Intercept e12.54 2.17 <.001
Open procedure 1.35 0.37 <.001
Age 0.09 0.03 .001
Female gender 0.88 0.36 .014
Myocardial disease 0.62 0.36 .088
Vascular disease 0.80 0.42 .060
Congestive heart failure 0.88 0.41 .032
COPD 0.55 0.36 .126
ASA: life threat/moribund 0.90 0.80 .260
ASA, American Society of Anesthesiologists; COPD, chronic obstructive
pulmonary disease; SE, standard error.rate showed very good predictive ability (area under the curve ¼ .737;
Fig). Vuong tests yielded a signiﬁcant ﬁt difference favoring Medicare and
VSGNE to Glasgow Aneurysm Score model, whereas Medicare and
VSGNE compared similarly (Fig). Across three risk terciles, the VSGNE
model predicted observed mortality reasonably well.
Conclusions: The VSGNE AAA RPM was externally validated on
NSQIP AAA patients and showed a high ﬁdelity for predicting EARmortality
performed by a diverse array of physicians. A risk score based on this model
can reliably stratify patients according to their risk of mortality after EAR.
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Objectives: Median arcuate ligament syndrome (MALS) results from
celiac artery compression by the MAL and is most often associated with
chronic abdominal pain. The objective of this study was to evaluate the out-
comes of MALS after celiac artery decompression (CAD).
Methods: A retrospective analysis was completed using theNationwide
Inpatient Sample based on International Classiﬁcation of Diseases, Ninth
Revision, Clinical Modiﬁcation codes for MALS (447.4) and CAD (39.91)
for patient admissions between 1999 and 2011 in the U.S. Demographic
covariates included age and gender. Clinical covariates included Diagnosis-
Related Group (DRG) severity of illness scores, mortality scores, comorbid-
ities, and hospital covariates. Outcomes included inpatient mortality, median
length of stay in days, and adjusted median hospital costs. Data analysis was
completed using the IBM SPSS 20 software (IBM Corp, Armonk, NY).
Results: We identiﬁed 33,951 patients who were diagnosed with
MALS and 1029 patients who underwent CAD. Demographics, comorbid-
ities, hospital covariates, and outcomes are reported in the Table. Although
the results indicate increased mortality in patients who do not undergo sur-
gery (MALS: 2.6% vs CAD: 0%; P < .001), this is more likely due to higher
DRG severity of illness (MALS: 2.7; CAD: 1.7; P < .001) and risk of mor-
tality (MALS: 2.3; CAD: 1.2; P < .001). The incidence of MALS has
increased steadily since the year 2000, yet only 2.44% of patients, on
average, identiﬁed with MALS undergo CAD.
Conclusions: The outcomes of CAD for MALS are excellent. While
the incidence of MALS has increased, very few patients undergo CAD.
This may represent an opportunity to educate physicians regarding the diag-
nosis and treatment of MALS.
Table. Demographics, comorbidities, hospital covariates, and outcomes
in patients with median arcuate ligament syndrome (MALS) and in those
who undergo celiac artery decompression (CAD)
Variable MALS CAD P
Demographics
Age 67.9 6 15.7 40.9 6 17.4 <.001
Female, % 66.9 73.9 <.001
Chronic conditions, No. 7.3 6 3.1 3.5 6 2.3 <.001
Diagnoses on record, No. 11.3 6 5.3 6.3 6 4.6 <.001
DRG severity of illness 2.7 6 0.7 1.7 6 0.8 <.001
DRG risk of mortality 2.3 6 0.9 1.2 6 0.5 <.001
Comorbidities, %
Iron deﬁciency anemia 19.8 4.7 <.001
Congestive heart failure 11.2 0.0 <.001
COPD 25.1 12.2 <.001
Depression 12.8 9.3 <.01
Diabetes 17.1 3.1 <.001
Hypertension 61.1 22.4 <.001
Fluid and electrolyte
disorders
28.1 9.5 <.001
Peripheral vascular disorder 49.5 14.3 <.001
Renal failure 15.5 0.8 <.001
Weight loss 12.4 10.0 NS
Hospital covariates
Urban hospital location 92.2 97.3 <.001
Teaching hospital 51.5 82.2 <.001
Outcomes
Length of stay, days 5 (3-8) 4 (3-7) NS
Total costs in 2014 US $ $13,129
(7716-22,628)
$16,107
(11,466-23,610)
<.01
Inpatient mortality 2.6 0.0 <.001
COPD, Chronic obstructive pulmonary disease; NS, not signiﬁcant; US,
United States.
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Objectives: Splenic artery aneurysms (SAAs) are rare, with an
overall estimated incidence of <0.01%. Open surgical techniques
have traditionally been used to treat or exclude SAAs. More recently,
endovascular procedures have emerged as a preferred treatment.
However, evidence to support an endovascular management strategy
for SAA is limited to few case series and mostly individual case
reports.
Methods: We used the Nationwide Inpatient Sample (NIS) and
gathered data from 2008 to 2011 to compare open vs endovascular SAA
repair by assessing postoperative outcomes, hospital length of stay, and
mortality.
Results: There were 2316 admissions during the study period
with a diagnosis code for SAA. Among these admissions, 347 pa-
tients (14.9%) underwent endovascular repair and 112 patients
(4.8%) underwent open surgery. There was a statistically signiﬁcantly
lower rate of cardiac (2.3% vs 6.9%; P ¼ .05) and pulmonary (8.9%
vs 16.1%; P ¼ .05) complications in patients undergoing endovascu-
lar repair compared with those undergoing open surgery. In addi-
tion, the risk of surgical site infection in endovascularly treated
SAA was also lower (0.6% vs 5.1%; P ¼ .01). In-hospital length of
stay was signiﬁcantly greater for open repairs than for endovascular
repairs (6 vs 4 days, respectively; P ¼ .01). There were no statisti-
cally signiﬁcant differences across procedures for renal complications
(8.9% in both groups; P ¼ .88) or in-hospital mortality (3% in both
groups; P ¼ .99).
Conclusions: In this observational study, endovascular repair of SAA
is associated with a lower complication rate and less resource utilization but
no difference in mortality perioperatively compared with open surgery.
This may justify an endovascular-ﬁrst treatment strategy in the manage-
ment of SAA.
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